See 10-15% upside in midcap pharma space: Vineet Bhatnagar

Vineet Bhatnagar - MD at Phillip Capital told CNBC-TV18, "Wockhardt has given stupendous returns. If one were to play on the pharma stocks and even with the training view I would look at the midcap pharma stocks to show another 10-15 percent upside."

"The names that come to our mind are Glenmark Pharma, Divis Laboratories, Torrent Pharma and Cadila Healthcare. These are the names we are looking at to play on the trading side for pharma sector in the midcap space," he added.

"I am looking for a possible correction of about 3-5 percent in the large pharma companies. However, if Dr Reddy's Laboratories, Sun Pharma and Lupin were to show me another 3-5 percent downside then that will be the support at which I may like to accumulate these names."

Disclosure: Analyst may personally have some propositions in the midcap space about the names mentioned. They could also be names that appear in the proprietary trading book that he has in Phillip Capital.